Status:
UNKNOWN
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Nicotine Dependence
Smoking
Eligibility:
FEMALE
18-30 years
Phase:
NA
Brief Summary
This research project addresses the hypothesis that a neurocognitive profile characterized by impairment of response inhibition and sustained attention may be a risk factor for smoking initiation and ...
Eligibility Criteria
Inclusion
- Reported smoking cigarettes on a daily basis at the time of the original study and continue to smoke currently
- Manifested poor performance on the MFFT (The neurocognitive test that yielded differences between smokers and non-smokers)
- Competent and willing to give written informed consent
Exclusion
- Pregnancy, breast-feeding, non-use of contraception such that the possibility of pregnancy cannot be excluded
- Intake of any medication that may potentially interact with nicotine.
- Any current or past medical condition that represents a contra-indication to nicotine administration.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00429208
Start Date
February 1 2007
End Date
April 1 2007
Last Update
January 31 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel